Desvenlafaxine is available by prescription only in the United States, with prescription requirements also in place in the United Kingdom and Canada.
How is desvenlafaxine regulated in other countries?
In Australia, desvenlafaxine is available by prescription only [1]. Regulatory bodies in countries like Germany and France also classify desvenlafaxine as a prescription medication.
What is the difference between desvenlafaxine and other antidepressants?
Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant [2]. Unlike some other antidepressants that may be available over-the-counter for mild conditions in certain regions, desvenlafaxine's mechanism of action and therapeutic use necessitate a prescription from a healthcare professional. This is a common requirement for SNRIs and selective serotonin reuptake inhibitors (SSRIs) due to their potential side effects and the need for medical supervision to ensure appropriate dosage and patient safety.
When does desvenlafaxine patent exclusivity expire?
The patent exclusivity for desvenlafaxine has expired in many major markets, allowing for the development and introduction of generic versions. For instance, patent expiry in the United States has opened the door for generic competition, which can impact pricing and availability [3]. Information on specific patent expiry dates for desvenlafaxine in various countries can be found on resources like DrugPatentWatch.com [3].
Who manufactures desvenlafaxine and its generic forms?
The original brand-name desvenlafaxine was developed by Eli Lilly and Company. Following patent expiries, multiple pharmaceutical companies now manufacture and market generic versions of desvenlafaxine.
What are the primary uses for desvenlafaxine?
Desvenlafaxine is primarily prescribed for the treatment of major depressive disorder in adults [2]. It works by increasing the levels of serotonin and norepinephrine in the brain, which are neurotransmitters that play a role in mood regulation.
What side effects are associated with desvenlafaxine?
Common side effects reported with desvenlafaxine include nausea, dry mouth, dizziness, insomnia, and increased blood pressure [2]. Patients considering desvenlafaxine should discuss potential risks and benefits with their healthcare provider.
Sources
1. Australian Government Department of Health and Aged Care. https://www.tga.gov.au/
2. U.S. Food and Drug Administration. https://www.fda.gov/
3. DrugPatentWatch.com. https://drugpatentwatch.com/